Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease (Q30234830)

11 June 2017

Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease (English)

1 reference

11 June 2017

hepatocellular carcinoma

1 reference

metabolic dysfunction–associated steatotic liver disease

inferred from title

1 reference

non-alcoholic fatty liver

inferred from title

1 reference

Elisabetta Degasperi

1

1 reference

PubMed ID

28404072

11 June 2017

Massimo Colombo

series ordinal

2

1 reference

PubMed ID

28404072

11 June 2017

language of work or name

1 reference

8 September 2016

1 reference

The lancet. Gastroenterology & hepatology

11 June 2017

1 reference

11 June 2017

1

1 reference

11 June 2017

156-164

1 reference

11 June 2017

2

1 reference

11 June 2017

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Epidemiology of viral hepatitis and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Nonalcoholic fatty liver disease in Asia: a story of growth

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Management of hepatocellular carcinoma: An update

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: a review of human studies

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

NAFLD in Asia--as common and important as in the West

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Epidemiology of non-alcoholic fatty liver disease in China.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Prevalence and risk factors for the development of nonalcoholic fatty liver disease in a nonobese Chinese population: the Zhejiang Zhenhai Study.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Difference in malignancies of chronic liver disease due to non-alcoholic fatty liver disease or hepatitis C in Japanese elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Clinical features and outcome of cryptogenic hepatocellular carcinoma compared to those of viral and alcoholic hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Meta-analysis of epidemiologic studies on cigarette smoking and liver cancer

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Liver disease in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Diabetes mellitus and cancer risk in a network of case-control studies

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Metabolic syndrome and hepatocellular carcinoma risk

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Modest alcohol consumption decreases the risk of non-alcoholic fatty liver disease: a meta-analysis of 43 175 individuals

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Modest alcohol consumption reduces the incidence of fatty liver in men: a population-based large-scale cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

The combined effects of alcohol consumption and body mass index on hepatic steatosis in a general population sample of European men and women.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

The steatohepatitic variant of hepatocellular carcinoma and its association with underlying steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Hepatocellular carcinoma with steatohepatitic features: a clinicopathological study of Japanese patients

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Failure rates in the hepatocellular carcinoma surveillance process.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Surveillance for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease--the role of transient elastography and plasma cytokeratin-18 fragments

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Pathology of early hepatocellular carcinoma: conventional and molecular diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Liver resection for hepatocellular carcinoma in patients with metabolic syndrome: A multicenter matched analysis with HCV-related HCC.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Hepatic steatosis is associated with surgical-site infection after hepatic and colorectal surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Fatty liver in liver transplantation and surgery

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Features, diagnosis, and treatment of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Hepatocellular carcinoma risk prediction model for the general population: the predictive power of transaminases

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Regular exercise decreases liver tumors development in hepatocyte-specific PTEN-deficient mice independently of steatosis

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Metformin for liver cancer prevention in patients with type 2 diabetes: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930018-8

7 January 2021

10.1016/S2468-1253(16)30018-8

Identifiers

DOI

1 reference

11 June 2017

1 reference

PubMed ID

28404072